Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Filter By Podcast Format

 
 
 
 
 
Tune-in as Dr. Hobbs discusses symptom scoring, risk stratification, and effective practices in building a strong myelofibrosis program.
Listen as Cindy Varga, MD, discusses the positives and negatives with subcutaneous versus intravenous drugs in treating patients with multiple myeloma.
Learn more about a care delivery model that can identify, implement, and expedite patient lung nodule care in real time and provide consistent follow-up along the continuum of care.
Learn how recent guideline and treatment options by the National Comprehensive Cancer Network (NCCN) can optimize care for patients with MPNs.
Hear suggestions for how to reduce financial hurdles and increase access to cancer diagnostics.
As cancer programs seek new ways to improve coordination of molecular testing, hear how precision medicine stewards can streamline testing processes to improve efficiency and improve the patient experience.
As myeloproliferative neoplasms (MPNs) carry a significant symptom burden and oftentimes can require lifelong care coordination and close monitoring, hear how a strong multidisciplinary approach can impact shared decision-making and patient engagement.
Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems. Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.
Hear the most up-to-date best practices, including shared decision-making, regarding treating patients with CLL in this post-COVID era.
As community care teams work to provide equitable care for patients with chronic lymphocytic leukemia (CLL), understanding disparities as well as state and region-specific barriers that impact care is critical.
Andre Harvin teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about innovative solutions to streamline pharmacy operations that have saved his healthcare system millions of dollars. One of those innovative solutions—robotic pharmacists.
Kevin Davies, PhD, author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about the history of genome technology and its potential to change precision medicine.
CANCER BUZZ speaks with Srdan Verstovsek, MD, PhD, about when to begin therapeutic care for myeloproliferative neoplasms (MPNs) and the urgency of treatment.
Learn about population health navigators—individuals dedicated to supporting a specific underserved population, including rural, Black, and Latinx populations, through culturally and linguistically competent navigation services for patients with cancer, their families, and their caregivers.
Multidisciplinary care coordination is especially important with aggressive cases of SCLC, as there may be several unique challenges to be addressed. Watch now!
Learn about a nurse’s role in care planning, and engaging patients in education, and shared decision making for treatment goals and planning.
To celebrate its 100th episode, CANCER BUZZ talks to ACCC Board Member and Treasurer Dr. Nadine Barrett about her journey with the Association of Community Cancer Centers.
Hear why community practices need to monitor symptoms carefully and about a new tool that can help assess symptoms more accurately and help care teams form treatment plans.
As interest continues to build around multi-cancer early detection, hear what care teams need to know about the technology and the legislative outlook for coverage for this revolutionary testing.
Learn how multidisciplinary care coordination and timely diagnosis are critical in the health outcomes of patients with SCLC.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.